UniProtKB - P62993 (GRB2_HUMAN)
(max 400 entries)x
Your basket is currently empty.
Select item(s) and click on "Add to basket" to create your own collection here
(400 entries max)
Protein
Growth factor receptor-bound protein 2
Gene
GRB2
Organism
Homo sapiens (Human)
Status
Functioni
Adapter protein that provides a critical link between cell surface growth factor receptors and the Ras signaling pathway.
Isoform 2 does not bind to phosphorylated epidermal growth factor receptor (EGFR) but inhibits EGF-induced transactivation of a RAS-responsive element. Isoform 2 acts as a dominant negative protein over GRB2 and by suppressing proliferative signals, may trigger active programmed cell death.
GO - Molecular functioni
- 1-phosphatidylinositol-3-kinase activity Source: Reactome
- ephrin receptor binding Source: UniProtKB
- epidermal growth factor receptor binding Source: UniProtKB
- identical protein binding Source: IntAct
- insulin receptor substrate binding Source: UniProtKB
- neurotrophin TRKA receptor binding Source: UniProtKB
- non-membrane spanning protein tyrosine kinase activity Source: GO_Central
- phosphatidylinositol-4,5-bisphosphate 3-kinase activity Source: Reactome
- phosphotyrosine binding Source: CAFA
- protein kinase binding Source: BHF-UCL
- protein phosphatase binding Source: Ensembl
- Ras guanyl-nucleotide exchange factor activity Source: Reactome
- RNA binding Source: UniProtKB
- SH3/SH2 adaptor activity Source: UniProtKB
- SH3 domain binding Source: UniProtKB
GO - Biological processi
- aging Source: Ensembl
- anatomical structure formation involved in morphogenesis Source: Ensembl
- axon guidance Source: Reactome
- branching involved in labyrinthine layer morphogenesis Source: Ensembl
- cell-cell signaling Source: UniProtKB
- cell differentiation Source: GO_Central
- cell migration Source: GO_Central
- cellular response to ionizing radiation Source: BHF-UCL
- entry of bacterium into host cell Source: Reactome
- epidermal growth factor receptor signaling pathway Source: UniProtKB
- ERBB2 signaling pathway Source: Reactome
- Fc-epsilon receptor signaling pathway Source: Reactome
- Fc-gamma receptor signaling pathway involved in phagocytosis Source: Reactome
- fibroblast growth factor receptor signaling pathway Source: Reactome
- innate immune response Source: GO_Central
- insulin receptor signaling pathway Source: UniProtKB
- leukocyte migration Source: Reactome
- MAPK cascade Source: Reactome
- membrane organization Source: Reactome
- negative regulation of epidermal growth factor receptor signaling pathway Source: Reactome
- peptidyl-tyrosine autophosphorylation Source: GO_Central
- phosphatidylinositol-mediated signaling Source: Reactome
- positive regulation of actin filament polymerization Source: Ensembl
- positive regulation of reactive oxygen species metabolic process Source: BHF-UCL
- protein heterooligomerization Source: Ensembl
- Ras protein signal transduction Source: UniProtKB
- receptor internalization Source: BHF-UCL
- regulation of cell proliferation Source: GO_Central
- regulation of MAPK cascade Source: Ensembl
- regulation of phosphatidylinositol 3-kinase signaling Source: Reactome
- signal transduction in response to DNA damage Source: BHF-UCL
- T cell costimulation Source: Reactome
- viral process Source: UniProtKB-KW
Keywordsi
| Biological process | Host-virus interaction |
Enzyme and pathway databases
| Reactomei | R-HSA-109704. PI3K Cascade. R-HSA-112412. SOS-mediated signalling. R-HSA-114604. GPVI-mediated activation cascade. R-HSA-1236382. Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants. R-HSA-1250196. SHC1 events in ERBB2 signaling. R-HSA-1250347. SHC1 events in ERBB4 signaling. R-HSA-1257604. PIP3 activates AKT signaling. R-HSA-1295596. Spry regulation of FGF signaling. R-HSA-1433557. Signaling by SCF-KIT. R-HSA-1433559. Regulation of KIT signaling. R-HSA-167044. Signalling to RAS. R-HSA-179812. GRB2 events in EGFR signaling. R-HSA-180292. GAB1 signalosome. R-HSA-180336. SHC1 events in EGFR signaling. R-HSA-182971. EGFR downregulation. R-HSA-1839117. Signaling by cytosolic FGFR1 fusion mutants. R-HSA-186763. Downstream signal transduction. R-HSA-1963640. GRB2 events in ERBB2 signaling. R-HSA-1963642. PI3K events in ERBB2 signaling. R-HSA-2029482. Regulation of actin dynamics for phagocytic cup formation. R-HSA-210993. Tie2 Signaling. R-HSA-2179392. EGFR Transactivation by Gastrin. R-HSA-2219530. Constitutive Signaling by Aberrant PI3K in Cancer. R-HSA-2424491. DAP12 signaling. R-HSA-2428933. SHC-related events triggered by IGF1R. R-HSA-2730905. Role of LAT2/NTAL/LAB on calcium mobilization. R-HSA-2871796. FCERI mediated MAPK activation. R-HSA-2871809. FCERI mediated Ca+2 mobilization. R-HSA-354194. GRB2:SOS provides linkage to MAPK signaling for Integrins. R-HSA-375165. NCAM signaling for neurite out-growth. R-HSA-388841. Costimulation by the CD28 family. R-HSA-389359. CD28 dependent Vav1 pathway. R-HSA-391160. Signal regulatory protein (SIRP) family interactions. R-HSA-392451. G beta:gamma signalling through PI3Kgamma. R-HSA-512988. Interleukin-3, 5 and GM-CSF signaling. R-HSA-5637810. Constitutive Signaling by EGFRvIII. R-HSA-5654688. SHC-mediated cascade:FGFR1. R-HSA-5654689. PI-3K cascade:FGFR1. R-HSA-5654693. FRS-mediated FGFR1 signaling. R-HSA-5654695. PI-3K cascade:FGFR2. R-HSA-5654699. SHC-mediated cascade:FGFR2. R-HSA-5654700. FRS-mediated FGFR2 signaling. R-HSA-5654704. SHC-mediated cascade:FGFR3. R-HSA-5654706. FRS-mediated FGFR3 signaling. R-HSA-5654710. PI-3K cascade:FGFR3. R-HSA-5654712. FRS-mediated FGFR4 signaling. R-HSA-5654719. SHC-mediated cascade:FGFR4. R-HSA-5654720. PI-3K cascade:FGFR4. R-HSA-5654726. Negative regulation of FGFR1 signaling. R-HSA-5654727. Negative regulation of FGFR2 signaling. R-HSA-5654732. Negative regulation of FGFR3 signaling. R-HSA-5654733. Negative regulation of FGFR4 signaling. R-HSA-5655253. Signaling by FGFR2 in disease. R-HSA-5655291. Signaling by FGFR4 in disease. R-HSA-5655302. Signaling by FGFR1 in disease. R-HSA-5663213. RHO GTPases Activate WASPs and WAVEs. R-HSA-5673001. RAF/MAP kinase cascade. R-HSA-6807004. Negative regulation of MET activity. R-HSA-6811558. PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling. R-HSA-74749. Signal attenuation. R-HSA-74751. Insulin receptor signalling cascade. R-HSA-8851805. MET activates RAS signaling. R-HSA-8851907. MET activates PI3K/AKT signaling. R-HSA-8853334. Signaling by FGFR3 fusions in cancer. R-HSA-8853338. Signaling by FGFR3 point mutants in cancer. R-HSA-8853659. RET signaling. R-HSA-8856825. Cargo recognition for clathrin-mediated endocytosis. R-HSA-8856828. Clathrin-mediated endocytosis. R-HSA-8865999. MET activates PTPN11. R-HSA-8875360. InlB-mediated entry of Listeria monocytogenes into host cell. R-HSA-8875555. MET activates RAP1 and RAC1. R-HSA-8875656. MET receptor recycling. R-HSA-912526. Interleukin receptor SHC signaling. R-HSA-912631. Regulation of signaling by CBL. R-HSA-983695. Antigen activates B Cell Receptor (BCR) leading to generation of second messengers. |
| SignaLinki | P62993. |
| SIGNORi | P62993. |
Names & Taxonomyi
| Protein namesi | Recommended name: Growth factor receptor-bound protein 2Alternative name(s): Adapter protein GRB2 Protein Ash SH2/SH3 adapter GRB2 |
| Gene namesi | Name:GRB2 Synonyms:ASH |
| Organismi | Homo sapiens (Human) |
| Taxonomic identifieri | 9606 [NCBI] |
| Taxonomic lineagei | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
| Proteomesi |
|
Organism-specific databases
| HGNCi | HGNC:4566. GRB2. |
Subcellular locationi
- Nucleus 1 Publication
- Cytoplasm 1 Publication
- Endosome 1 Publication
- Golgi apparatus By similarity
GO - Cellular componenti
- cell-cell junction Source: Ensembl
- COP9 signalosome Source: UniProtKB
- cytoplasm Source: UniProtKB
- cytosol Source: HGNC
- endosome Source: UniProtKB
- extracellular exosome Source: UniProtKB
- extrinsic component of cytoplasmic side of plasma membrane Source: GO_Central
- Golgi apparatus Source: UniProtKB-SubCell
- Grb2-EGFR complex Source: BHF-UCL
- nucleolus Source: HPA
- nucleoplasm Source: HPA
- nucleus Source: UniProtKB
- plasma membrane Source: Reactome
- vesicle membrane Source: Ensembl
Keywords - Cellular componenti
Cytoplasm, Endosome, Golgi apparatus, NucleusPathology & Biotechi
Mutagenesis
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Mutagenesisi | 49 | P → L: Ineffective in DNA synthesis. Abolishes interaction with SHB; when associated with L-206. Abolishes interaction with SOS1. 3 Publications | 1 | |
| Mutagenesisi | 89 | E → K: No effect on the interaction with SOS1. 1 Publication | 1 | |
| Mutagenesisi | 90 | S → N: No effect on the interaction with SOS1. 1 Publication | 1 | |
| Mutagenesisi | 203 | G → R: Ineffective in DNA synthesis. Abolishes interaction with SOS1. 2 Publications | 1 | |
| Mutagenesisi | 206 | P → L: Abolishes interaction with SHB; when associated with L-49. 1 Publication | 1 |
Organism-specific databases
| DisGeNETi | 2885. |
| OpenTargetsi | ENSG00000177885. |
| PharmGKBi | PA28962. |
Chemistry databases
| ChEMBLi | CHEMBL3663. |
| DrugBanki | DB00061. Pegademase bovine. |
Polymorphism and mutation databases
| BioMutai | GRB2. |
| DMDMi | 51702266. |
PTM / Processingi
Molecule processing
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| ChainiPRO_0000088198 | 1 – 217 | Growth factor receptor-bound protein 2Add BLAST | 217 |
Amino acid modifications
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Modified residuei | 1 | N-acetylmethionineCombined sources | 1 | |
| Modified residuei | 6 | N6-acetyllysineCombined sources | 1 | |
| Modified residuei | 50 | N6-acetyllysineCombined sources | 1 | |
| Modified residuei | 109 | N6-acetyllysineCombined sources | 1 | |
| Modified residuei | 211 | PhosphothreonineCombined sources | 1 |
Keywords - PTMi
Acetylation, PhosphoproteinProteomic databases
| EPDi | P62993. |
| MaxQBi | P62993. |
| PaxDbi | P62993. |
| PeptideAtlasi | P62993. |
| PRIDEi | P62993. |
| TopDownProteomicsi | P62993-1. [P62993-1] P62993-2. [P62993-2] |
2D gel databases
| OGPi | P62993. |
| SWISS-2DPAGEi | P62993. |
PTM databases
| iPTMneti | P62993. |
| PhosphoSitePlusi | P62993. |
Expressioni
Gene expression databases
| Bgeei | ENSG00000177885. |
| CleanExi | HS_GRB2. |
| ExpressionAtlasi | P62993. baseline and differential. |
| Genevisiblei | P62993. HS. |
Organism-specific databases
| HPAi | CAB002589. HPA030749. HPA030750. |
Interactioni
Subunit structurei
Associates (via SH2 domain) with activated EGF and PDGF receptors (tyrosine phosphorylated) (PubMed:10026169, PubMed:19836242). Interacts with PDGFRA (tyrosine phosphorylated); the interaction may be indirect (By similarity). Also associates to other cellular Tyr-phosphorylated proteins such as SIT1, IRS1, IRS4, SHC and LNK; probably via the concerted action of both its SH2 and SH3 domains (PubMed:8388384, PubMed:8491186, PubMed:9553137, PubMed:11433379). It also seems to interact with RAS in the signaling pathway leading to DNA synthesis. Interacts with SOS1 (PubMed:8493579, PubMed:7664271). Forms a complex with MUC1 and SOS1, through interaction of the SH3 domains with SOS1 and the SH2 domain with phosphorylated MUC1 (PubMed:7664271). Interacts with phosphorylated MET (PubMed:11063574, PubMed:11827484). Interacts with phosphorylated TOM1L1 (By similarity). Interacts with the phosphorylated C-terminus of SH2B2 (PubMed:9233773). Interacts with phosphorylated SIT1, LAX1, LAT, LAT2 and LIME1 upon TCR and/or BCR activation (By similarity) (PubMed:9489702, PubMed:12359715, PubMed:12486104, PubMed:12514734). Interacts with NISCH, PTPNS1 and REPS2 (PubMed:9062191, PubMed:9422736, PubMed:11912194). Interacts with syntrophin SNTA1 (By similarity). Interacts (via SH3 domains) with REPS1 (By similarity). Interacts (via SH3 domains) with PIK3C2B (PubMed:11533253). Interacts with CBL and CBLB (PubMed:10022120, PubMed:10086340). Interacts with AJUBA and CLNK (By similarity). Interacts (via SH2 domain) with TEK/TIE2 (tyrosine phosphorylated) (By similarity). Interacts with SHB, INPP5D/SHIP1, SKAP1 and SKAP2 (PubMed:8723348, PubMed:9108392, PubMed:9484780, PubMed:10942756, PubMed:12171928). Interacts with PTPN11 (By similarity). Interacts with PRNP (By similarity). Interacts with RALGPS1 (PubMed:10747847). Interacts with HCST (PubMed:16582911). Interacts with KDR (By similarity). Interacts with FLT1 (tyrosine-phosphorylated) (By similarity). Interacts with GAPT and PTPRE (PubMed:10980613, PubMed:18559951). Interacts (via SH2 domain) with KIF26A (PubMed:19914172). Interacts (via SH3 2) with GAB2 (PubMed:19523899). Interacts with ADAM15 (PubMed:18296648). Interacts with THEMIS2 (By similarity). Interacts (via SH2 domain) with AXL (phosphorylated) (PubMed:9178760, PubMed:19815557). Interacts (via SH2 domain) with KIT (phosphorylated) (PubMed:15526160, PubMed:16129412). Interacts with PTPRJ and BCR (PubMed:12475979, PubMed:15302586). Interacts with PTPN23 (PubMed:21179510). Interacts with FLT4 (tyrosine phosphorylated) (PubMed:15102829). Interacts with EPHB1 and SHC1; activates the MAPK/ERK cascade to regulate cell migration (PubMed:8798570, PubMed:12925710). Part of a complex including TNK2, GRB2, LTK and one receptor tyrosine kinase (RTK) such as AXL and PDGFRL, in which GRB2 promotes RTK recruitment by TNK2 (PubMed:9178760, PubMed:19815557). Interacts (via SH2 domain) with CSF1R (tyrosine phosphorylated) (PubMed:8262059). Interacts with ERBB4 (PubMed:10867024). Interacts with NTRK1 (phosphorylated upon ligand-binding) (PubMed:15488758). Interacts with PTK2/FAK1 (tyrosine phosphorylated) (PubMed:9148935). Interacts with PTK2B/PYK2 (tyrosine phosphorylated) (PubMed:20521079). Isoform 1 interacts with SCIMP (PubMed:21930792). Interacts (via SH3 domains) with GAREM1 isoform 1 (via proline-rich domain and tyrosine phosphorylated); the interaction occurs upon EGF stimulation (PubMed:19509291). Interacts with DAB2 (By similarity). Interacts with TESPA1 (PubMed:22561606). Interacts with PLCG1, LAT and THEMIS upon TCR activation in thymocytes; the association is weaker in the absence of TESPA1 (By similarity). Interacts with CD28 (PubMed:24098653). Interacts with RAB13; may recruit RAB13 to the leading edge of migrating endothelial cells where it can activate RHOA (By similarity). Interacts with ASAP3 (phosphorylated form) (PubMed:22027826). Interacts (via SH3 domain) with HEV ORF3 protein (PubMed:11518702). Interacts with HCV NS5A via its SH3 domains (PubMed:10318918). Interacts with herpes simplex virus 1 UL46 (PubMed:23946459). Interacts (via SH2 domain) with PTPRH (phosphorylated form) (By similarity). Interacts with PTPRO (phosphorylated form) (By similarity). Interacts with PTPRB (phosphorylated form) (By similarity).By similarity54 Publications
Binary interactionsi
GO - Molecular functioni
- ephrin receptor binding Source: UniProtKB
- epidermal growth factor receptor binding Source: UniProtKB
- identical protein binding Source: IntAct
- insulin receptor substrate binding Source: UniProtKB
- neurotrophin TRKA receptor binding Source: UniProtKB
- phosphotyrosine binding Source: CAFA
- protein kinase binding Source: BHF-UCL
- protein phosphatase binding Source: Ensembl
- SH3/SH2 adaptor activity Source: UniProtKB
- SH3 domain binding Source: UniProtKB
Protein-protein interaction databases
| BioGridi | 109142. 535 interactors. |
| DIPi | DIP-29229N. |
| IntActi | P62993. 772 interactors. |
| MINTi | MINT-91952. |
| STRINGi | 9606.ENSP00000339007. |
Chemistry databases
| BindingDBi | P62993. |
Structurei
Secondary structure
Legend: HelixTurnBeta strandPDB Structure known for this area
Show more details| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Beta strandi | 2 – 5 | Combined sources | 4 | |
| Beta strandi | 13 – 15 | Combined sources | 3 | |
| Beta strandi | 24 – 26 | Combined sources | 3 | |
| Beta strandi | 36 – 43 | Combined sources | 8 | |
| Beta strandi | 45 – 49 | Combined sources | 5 | |
| Helixi | 50 – 52 | Combined sources | 3 | |
| Beta strandi | 61 – 64 | Combined sources | 4 | |
| Helixi | 67 – 75 | Combined sources | 9 | |
| Beta strandi | 78 – 80 | Combined sources | 3 | |
| Beta strandi | 82 – 87 | Combined sources | 6 | |
| Turni | 89 – 93 | Combined sources | 5 | |
| Beta strandi | 95 – 101 | Combined sources | 7 | |
| Beta strandi | 104 – 112 | Combined sources | 9 | |
| Beta strandi | 114 – 116 | Combined sources | 3 | |
| Beta strandi | 118 – 122 | Combined sources | 5 | |
| Beta strandi | 124 – 127 | Combined sources | 4 | |
| Helixi | 128 – 134 | Combined sources | 7 | |
| Turni | 135 – 137 | Combined sources | 3 | |
| Beta strandi | 142 – 144 | Combined sources | 3 | |
| Beta strandi | 149 – 152 | Combined sources | 4 | |
| Beta strandi | 155 – 157 | Combined sources | 3 | |
| Beta strandi | 160 – 165 | Combined sources | 6 | |
| Beta strandi | 171 – 174 | Combined sources | 4 | |
| Beta strandi | 182 – 187 | Combined sources | 6 | |
| Beta strandi | 190 – 198 | Combined sources | 9 | |
| Beta strandi | 201 – 206 | Combined sources | 6 | |
| Helixi | 207 – 209 | Combined sources | 3 | |
| Beta strandi | 210 – 212 | Combined sources | 3 |
3D structure databases
| Select the link destinations: PDBei RCSB PDBi PDBji Links Updated | PDB entry | Method | Resolution (Å) | Chain | Positions | PDBsum |
| 1AZE | NMR | - | A | 1-56 | [»] | |
| 1BM2 | X-ray | 2.10 | A | 49-163 | [»] | |
| 1BMB | X-ray | 1.80 | A | 49-168 | [»] | |
| 1CJ1 | X-ray | 3.00 | A/B/C/D/E/F/G/H/I/J/K/L | 57-152 | [»] | |
| 1FHS | NMR | - | A | 53-163 | [»] | |
| 1FYR | X-ray | 2.40 | A/B/C/D | 50-161 | [»] | |
| 1GCQ | X-ray | 1.68 | A/B | 159-217 | [»] | |
| 1GFC | NMR | - | A | 159-215 | [»] | |
| 1GFD | NMR | - | A | 159-215 | [»] | |
| 1GHU | NMR | - | A | 60-158 | [»] | |
| 1GRI | X-ray | 3.10 | A/B | 1-217 | [»] | |
| 1IO6 | NMR | - | A | 159-215 | [»] | |
| 1JYQ | X-ray | 2.00 | A/B | 60-151 | [»] | |
| 1JYR | X-ray | 1.55 | A | 60-151 | [»] | |
| 1JYU | X-ray | 2.75 | A | 60-151 | [»] | |
| 1QG1 | NMR | - | E | 58-159 | [»] | |
| 1TZE | X-ray | 2.10 | E | 55-152 | [»] | |
| 1X0N | NMR | - | A | 58-159 | [»] | |
| 1ZFP | X-ray | 1.80 | E | 56-153 | [»] | |
| 2AOA | X-ray | 1.99 | A/B | 55-153 | [»] | |
| 2AOB | X-ray | 1.80 | A/B/C/D | 55-153 | [»] | |
| 2H46 | X-ray | 1.90 | E | 53-162 | [»] | |
| 2H5K | X-ray | 3.25 | A/B | 53-162 | [»] | |
| 2HUW | X-ray | 1.90 | A/B | 53-162 | [»] | |
| 2VVK | X-ray | 1.60 | A | 161-214 | [»] | |
| 2VWF | X-ray | 1.58 | A | 159-214 | [»] | |
| 2W0Z | X-ray | 1.70 | A | 159-214 | [»] | |
| 3C7I | X-ray | 1.70 | A | 53-162 | [»] | |
| 3IMD | X-ray | 2.00 | A/B | 53-163 | [»] | |
| 3IMJ | X-ray | 2.02 | A/B | 53-163 | [»] | |
| 3IN7 | X-ray | 2.00 | A/C | 53-163 | [»] | |
| 3IN8 | X-ray | 1.70 | A | 53-163 | [»] | |
| 3KFJ | X-ray | 2.02 | A | 53-163 | [»] | |
| 3MXC | X-ray | 2.00 | A | 55-152 | [»] | |
| 3MXY | X-ray | 2.30 | A | 55-152 | [»] | |
| 3N7Y | X-ray | 2.02 | A/B/C | 55-152 | [»] | |
| 3N84 | X-ray | 2.00 | A/B/C/D/E/F | 53-163 | [»] | |
| 3N8M | X-ray | 2.00 | A | 53-163 | [»] | |
| 3OV1 | X-ray | 1.60 | A | 53-163 | [»] | |
| 3OVE | X-ray | 1.82 | A | 53-163 | [»] | |
| 3S8L | X-ray | 1.71 | A | 53-163 | [»] | |
| 3S8N | X-ray | 1.71 | A | 53-163 | [»] | |
| 3S8O | X-ray | 1.85 | A | 53-163 | [»] | |
| 3WA4 | X-ray | 1.35 | A | 60-152 | [»] | |
| 4P9V | X-ray | 1.64 | A | 53-163 | [»] | |
| 4P9Z | X-ray | 1.80 | A | 53-163 | [»] | |
| 5CDW | X-ray | 2.60 | A/B/C/E/G/H/K/L/O/P/U/V/Y/Z/c/d | 54-153 | [»] | |
| DisProti | DP00210. | |||||
| ProteinModelPortali | P62993. | |||||
| SMRi | P62993. | |||||
| ModBasei | Search... | |||||
| MobiDBi | Search... | |||||
Miscellaneous databases
| EvolutionaryTracei | P62993. |
Family & Domainsi
Domains and Repeats
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Domaini | 1 – 58 | SH3 1PROSITE-ProRule annotationAdd BLAST | 58 | |
| Domaini | 60 – 152 | SH2PROSITE-ProRule annotationAdd BLAST | 93 | |
| Domaini | 156 – 215 | SH3 2PROSITE-ProRule annotationAdd BLAST | 60 |
Domaini
The SH3 domains mediate interaction with RALGPS1 and SHB.
Sequence similaritiesi
Belongs to the GRB2/sem-5/DRK family.Curated
Keywords - Domaini
Repeat, SH2 domain, SH3 domainPhylogenomic databases
| eggNOGi | KOG3601. Eukaryota. ENOG410XR1G. LUCA. |
| GeneTreei | ENSGT00820000126999. |
| HOGENOMi | HOG000251625. |
| HOVERGENi | HBG005404. |
| InParanoidi | P62993. |
| KOi | K04364. |
| OMAi | HWWHGEI. |
| OrthoDBi | EOG091G0HWS. |
| PhylomeDBi | P62993. |
| TreeFami | TF354288. |
Family and domain databases
| Gene3Di | 3.30.505.10. 1 hit. |
| InterProi | View protein in InterPro IPR000980. SH2. IPR001452. SH3_domain. |
| Pfami | View protein in Pfam PF00017. SH2. 1 hit. PF00018. SH3_1. 2 hits. |
| PRINTSi | PR00401. SH2DOMAIN. PR00452. SH3DOMAIN. |
| SMARTi | View protein in SMART SM00252. SH2. 1 hit. SM00326. SH3. 2 hits. |
| SUPFAMi | SSF50044. SSF50044. 2 hits. SSF55550. SSF55550. 2 hits. |
| PROSITEi | View protein in PROSITE PS50001. SH2. 1 hit. PS50002. SH3. 2 hits. |
Sequences (2)i
Sequence statusi: Complete.
This entry describes 2 isoformsi produced by alternative splicing. AlignAdd to basket
Note: Additional isoforms seem to exist.
Isoform 1 (identifier: P62993-1) [UniParc]FASTAAdd to basket
Also known as: Ash-L
This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.
10 20 30 40 50
MEAIAKYDFK ATADDELSFK RGDILKVLNE ECDQNWYKAE LNGKDGFIPK
60 70 80 90 100
NYIEMKPHPW FFGKIPRAKA EEMLSKQRHD GAFLIRESES APGDFSLSVK
110 120 130 140 150
FGNDVQHFKV LRDGAGKYFL WVVKFNSLNE LVDYHRSTSV SRNQQIFLRD
160 170 180 190 200
IEQVPQQPTY VQALFDFDPQ EDGELGFRRG DFIHVMDNSD PNWWKGACHG
210
QTGMFPRNYV TPVNRNV
Alternative sequence
| Feature key | Position(s) | DescriptionActions | Graphical view | Length |
|---|---|---|---|---|
| Alternative sequenceiVSP_001839 | 60 – 100 | Missing in isoform 2. 1 PublicationAdd BLAST | 41 |
Sequence databases
| Select the link destinations: EMBLi GenBanki DDBJi Links Updated | M96995 mRNA. Translation: AAA58448.1. X62852 mRNA. Translation: CAA44664.1. L29511 mRNA. Translation: AAC37549.1. AF063618 AF063617 Genomic DNA. Translation: AAC72075.1. AF498925 mRNA. Translation: AAM21073.1. CR541942 mRNA. Translation: CAG46740.1. AC011933 Genomic DNA. No translation available. BC000631 mRNA. Translation: AAH00631.1. |
| CCDSi | CCDS11721.1. CCDS11722.1. [P62993-2] |
| PIRi | A43321. |
| RefSeqi | NP_002077.1. NM_002086.4. [P62993-1] NP_987102.1. NM_203506.2. [P62993-2] |
| UniGenei | Hs.444356. |
Genome annotation databases
| Ensembli | ENST00000316615; ENSP00000317360; ENSG00000177885. [P62993-2] ENST00000316804; ENSP00000339007; ENSG00000177885. [P62993-1] ENST00000392562; ENSP00000376345; ENSG00000177885. [P62993-1] ENST00000392563; ENSP00000376346; ENSG00000177885. [P62993-2] ENST00000392564; ENSP00000376347; ENSG00000177885. [P62993-1] |
| GeneIDi | 2885. |
| KEGGi | hsa:2885. |
| UCSCi | uc002jnx.5. human. |
Keywords - Coding sequence diversityi
Alternative splicingSimilar proteinsi
Links to similar proteins from the UniProt Reference Clusters (UniRef) at 100%, 90% and 50% sequence identity:| 100% | UniRef100 combines identical sequences and sub-fragments with 11 or more residues from any organism into one UniRef entry. |
| 90% | UniRef90 is built by clustering UniRef100 sequences that have at least 90% sequence identity to, and 80% overlap with, the longest sequence (a.k.a seed sequence). |
| 50% | UniRef50 is built by clustering UniRef90 seed sequences that have at least 50% sequence identity to, and 80% overlap with, the longest sequence in the cluster. |
Entry informationi
| Entry namei | GRB2_HUMAN | |
| Accessioni | P62993Primary (citable) accession number: P62993 Secondary accession number(s): P29354 Q63059 | |
| Entry historyi | Integrated into UniProtKB/Swiss-Prot: | August 31, 2004 |
| Last sequence update: | August 31, 2004 | |
| Last modified: | July 5, 2017 | |
| This is version 172 of the entry and version 1 of the sequence. See complete history. | ||
| Entry statusi | Reviewed (UniProtKB/Swiss-Prot) | |
| Annotation program | Chordata Protein Annotation Program | |
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | |
Miscellaneousi
Keywords - Technical termi
3D-structure, Complete proteome, Direct protein sequencing, Reference proteomeDocuments
- Human chromosome 17
Human chromosome 17: entries, gene names and cross-references to MIM - MIM cross-references
Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot - PDB cross-references
Index of Protein Data Bank (PDB) cross-references - SIMILARITY comments
Index of protein domains and families
